Acupoint Application in Patients with Chronic Stable Angina Pectoris: Study Protocol of a Randomized, Double-Blind, Controlled Trial

Table 2

Study Schedule.

	Screening	Baseline (randomization)	Treatment	Follow up
Week	−4	0	4	8
Informed consent	×
In/exclusion criteria		×
Vital signs	×	×	×
Medical history	×
Concomitant disease/medication	×	×	×	×
Diary card distributed/review	×	×	×	×
Total frequency of angina attack		×	×	×
VAS scoring		×	×	×
Consumption of nitroglycerin or Suxiao Jiuxin dropping pills		×	×	×
CCS angina class		×	×	×
SAQ scoring		×	×	×
SAS and SDS scoring		×	×	×
ECG		×	×	×
Echocardiography		×
Blood, urine, and stool tests		×
Blood glucose and lipid tests		×
Liver and renal function tests		×
AEs		×	×	×
Reasons to withdrawal			×	×
Safety evaluation		×	×
Compliance		×	×	×

CCS = the Canadian Cardiovascular Society; SAQ = Seattle Angina Questionnaire; SAS = self-rating anxiety scale; SDS = self-rating depression scale; VAS = visual analogue scale; ECG = electrocardiograph; and AEs = adverse events.